Essex Bio-Technology (HKSE:01061) Construction In Progress : HK$188 Mil (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Essex Bio-Technology Construction In Progress?

Essex Bio-Technology's quarterly construction in progress declined from Dec. 2023 (HK$151 Mil) to Jun. 2024 (HK$139 Mil) but then increased from Jun. 2024 (HK$139 Mil) to Dec. 2024 (HK$188 Mil).

Essex Bio-Technology's annual construction in progress increased from Dec. 2022 (HK$134 Mil) to Dec. 2023 (HK$151 Mil) and increased from Dec. 2023 (HK$151 Mil) to Dec. 2024 (HK$188 Mil).

Essex Bio-Technology Construction In Progress Historical Data

The historical data trend for Essex Bio-Technology's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Essex Bio-Technology Construction In Progress Chart

Essex Bio-Technology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Construction In Progress

Get a 7-Day Free Trial

100.34

173.95

134.05

151.10

187.57

Essex Bio-Technology Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Construction In Progress	Get a 7-Day Free Trial															134.05	123.31	151.10	138.75	187.57

Essex Bio-Technology Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Essex Bio-Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Essex Bio-Technology Ltd (HKSE:01061) » Definitions » Construction In Progress

Traded in Other Exchanges

N/A

Address

No. 88, Keji 6th Road, Hi-Tech Zone, Guangdong, Zhuhai, CHN

Website

http://www.essexbio.com

Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash. The majority of the groups revenue comes from PRC.

Executives

Lauw Hui Kian
Ngiam Mia Je Patrick
Ngiam Mia Kiat Benjamin	2101 Beneficial owner

Essex Bio-Technology Headlines

No Headlines